Table 2 Cancer patient study population.
Description | n | % |
|---|---|---|
Histology | ||
Invasive ductal | 27 | 68 |
Invasive lobular | 2 | 5 |
Other | 11 | 28 |
Presenting stage of disease | ||
I | 5 | 13 |
II | 15 | 38 |
III | 8 | 20 |
IV | 8 | 20 |
Unknown | 4 | 10 |
Disease free interval | ||
0 | 11 | 28 |
1–9 yrs | 19 | 48 |
10+ yrs | 9 | 23 |
Unknown | 1 | 3 |
Hormone receptor status | ||
ER+/PR+ | 25 | 63 |
ER+/PR- | 8 | 20 |
ER-/PR+ | 1 | 3 |
ER-/PR- | 3 | 8 |
Unknown | 3 | 8 |
HER-2 / neu overexpression | ||
Positive | 4 | 10 |
Negative | 27 | 68 |
Unknown | 9 | 23 |